Lv4
536 积分 2023-09-01 加入
Translational Modeling and Simulation for Molecularly Targeted Small Molecule Anticancer Agents: Case Studies of Multiple Tyrosine Kinase Inhibitors, Crizotinib and Lorlatinib
1个月前
已完结
Early Drug Development: From a Drug Candidate to the Clinic
1个月前
已完结
Pharmacokinetic–Pharmacodynamic Modeling in Drug Development with Special Reference to Oncology
1个月前
已关闭
Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers
1个月前
已完结
BCS class IV drugs: Highly notorious candidates for formulation development
1个月前
已完结
Review of dose justifications for antibody-drug conjugate approvals from clinical pharmacology perspective: A focus on exposure-response analyses
2个月前
已完结
Practical guide to concentration-QTc modeling: a hands-on tutorial
2个月前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
2个月前
已完结
Benchmarking R&D success rates of leading pharmaceutical companies: an empirical analysis of FDA approvals (2006–2022)
2个月前
已完结
An IQ Consortium Perspective on Best Practices for Bioanalytical and Immunogenicity Assessment Aspects of CAR-T and TCR-T Cellular Therapies Development
3个月前
已完结
皖公网安备34019202002308
